Cephalon

Follow the Teva Pharmaceuticals company page for information, career opportunities and the latest company updates. Cephalon Inc. was established in 1987 as a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. In October 2011, Cephalon was acquired by Teva Pharmaceuticals, and is now a wholly owned subsidiary. The combination of companies has enabled Teva to deliver exceptional value for patients and customers across many therapeutic areas. Teva Pharmaceutical Industries Ltd.(NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately people around the world and reached $20.3 billion in net revenues in 2013.